EXOME SEQUENCING OF EXTREME PHENOTYPES IDENTIFIES DCTN4 AS A MODIFIER OF CHRONIC PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS

被引：0
|
作者：
Emond, M. J. [1 ]
Louie, T. [1 ]
Emerson, J. [2 ]
McNamara, S. [2 ]
Zhao, W. [1 ]
Mathias, R. [3 ]
Knowles, M. [4 ]
Wright, F. [4 ]
Rieder, M. [1 ]
Tabor, H. [2 ]
Nickerson, D. [1 ]
Barnes, K. [3 ]
Gibson, R. [2 ]
Bamshad, M. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Univ N Carolina, Chapel Hill, NC USA
来源：
PEDIATRIC PULMONOLOGY | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [21] The Costs of Treatment of Early and Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
    Braccini, G.
    Festini, F.
    Boni, V.
    Neri, A. S.
    Galici, V.
    Campana, S.
    Zavataro, L.
    Trevisan, F.
    Braggion, C.
    Taccetti, G.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 188 - 192
  • [22] Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Bilton, Diana
    Pressler, Tacjana
    Fajac, Isabelle
    Clancy, John Paul
    Sands, Dorota
    Minic, Predrag
    Cipolli, Marco
    Galeva, Ivanka
    Sole, Amparo
    Quittner, Alexandra L.
    Liu, Keith
    McGinnis, John R., II
    Eagle, Gina
    Gupta, Renu
    Konstan, Michael W.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (02) : 284 - 291
  • [23] Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection
    Staudinger, Benjamin J.
    Muller, Jocelyn Fraga
    Halldorsson, Skarpheoinn
    Boles, Blaise
    Angermeyer, Angus
    Dao Nguyen
    Rosen, Henry
    Baldursson, Olafur
    Gottfreosson, Magnus
    Guomundsson, Guomundur Hrafn
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (07) : 812 - 824
  • [24] CO-REGULATION OF PSEUDOMONAS AERUGINOSA POLYSACCHARIDES IN CHRONIC CYSTIC FIBROSIS INFECTION
    Cross, A. R.
    Goldberg, J. B.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 276 - 276
  • [25] PSEUDOMONAS-AERUGINOSA, MUCOIDY AND THE CHRONIC INFECTION PHENOTYPE IN CYSTIC-FIBROSIS
    DERETIC, V
    SCHURR, MJ
    YU, HW
    TRENDS IN MICROBIOLOGY, 1995, 3 (09) : 351 - 356
  • [26] Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis
    Elborn, J. Stuart
    Flume, Patrick A.
    Van Devanter, Donald R.
    Procaccianti, Claudio
    FUTURE MICROBIOLOGY, 2021, 16 (14) : 1087 - 1104
  • [27] Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection
    Steinkamp, Gratiana
    Schmitt-Grohe, Sabina
    Doering, Gerd
    Staab, Doris
    Pfruender, Dietmar
    Beck, Gudrun
    Schubert, Ralf
    Zielen, Stefan
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1643 - 1653
  • [28] Whole Exome Sequencing of Extreme Phenotypes of NAFLD Identifies Potential Genetic Risk Factors for Advanced Hepatic Fibrosis
    Urban, Thomas J.
    Moylan, Cynthia A.
    Rein, Matthew
    Abdelmalek, Manal F.
    Goldstein, David B.
    Diehl, Anna Mae
    HEPATOLOGY, 2014, 60 : 744A - 744A
  • [29] Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection
    Jain, Manu
    Bar-Meir, Maskit
    Mccolley, Susanna
    Cullina, Joanne
    Potter, Eileen
    Powers, Cathy
    Prickett, Michelle
    Seshadri, Roopa
    Jovanovic, Borko
    Petrocheilou, Argyri
    King, John D.
    Hauser, Alan R.
    TRANSLATIONAL RESEARCH, 2008, 152 (06) : 257 - 264
  • [30] Mouse models of chronic lung infection with Pseudomonas aeruginosa:: Models for the study of cystic fibrosis
    Stotland, PK
    Radzioch, D
    Stevenson, MM
    PEDIATRIC PULMONOLOGY, 2000, 30 (05) : 413 - 424
12345